Skip to content
DraconiticResearch
Search Sources API
186,546 studies31 sourcesUpdated 24 min ago
Peer-reviewedCC BY-NC-ND 4.0Scientific Reports

Myocardial extracellular volume reduction is associated with improved cardiac function after SGLT2 inhibitor therapy in HFpEF

  • Anastasios Marathonitis
  • Artemis Anastasiou
  • Nikolaos Vythoulkas-Biotis
  • Niki Lama
  • Panagiotis Theofilis
  • Georgios Marinos
  • Angeliki Margoni
  • Aikaterini Tsatsaragkou
  • Kostas Zisimos
  • Antonios Lysandrou
  • Evangelos Oikonomou
  • Gerasimos Siasos
1 more authors
  • Dimitris Tousoulis
Open at sourcePDFDOICite

Related

  1. Empagliflozin attenuates ISO-induced myocardial injury through PGC-1α-mediated mitochondrial biogenesis and improved fatty acid metabolism
    Chuyi Zhang, Xiandu Jin, Liping Wei +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textEndocrinology & metabolismCrossref
  2. Composite Haematological and Nutritional Indices Show No Evidence of Improved Long-Term Mortality Discrimination Beyond Their Own Components in Non-ST-Segment Elevation Myocardial Infarction
    Emrah Bozbeyoğlu, Aylin Sungur, Fatma Can +4
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Acute Myocardial Infarction from Stent Thrombosis Following a Loss to Follow-up Triggered by Financial Barriers to PCSK9 Inhibitor Therapy
    Tetsuro Nagao, Riku Arai, Tokio Nishiwaki +4
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaJ-STAGE
  4. BD2-selective BRD4 inhibitor ZX29 mitigates myocardial ischemia-reperfusion injury via BRD4-YY1-NCOA4 axis disruption and ferroptosis inhibition.
    Zeyu Li, Meixiu Xin, Zhongkai Wu +4
    Acta pharmaceutica Sinica. BPeer-reviewedCC BY-NC-NDFull text1 citedGeneral medicineEurope PMCPMC
  5. The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial
    Johann K Bauersachs, Scott David Solomon, Stefan D. Anker +11
    Nature MedicinePeer-reviewedCC BYFull text15 citedCardiovascular medicineOpenAlex

Cite

BibTeXRIS
BibTeX
@article{marathonitis2026myocardial,
  title = {{Myocardial extracellular volume reduction is associated with improved cardiac function after SGLT2 inhibitor therapy in HFpEF}},
  author = {Anastasios Marathonitis and Artemis Anastasiou and Nikolaos Vythoulkas-Biotis and Niki Lama and Panagiotis Theofilis and Georgios Marinos and Angeliki Margoni and Aikaterini Tsatsaragkou and Kostas Zisimos and Antonios Lysandrou and Evangelos Oikonomou and Gerasimos Siasos and Dimitris Tousoulis},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-75671-1},
  url = {https://www.nature.com/articles/s41598-026-75671-1},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Myocardial extracellular volume reduction is associated with improved cardiac function after SGLT2 inhibitor therapy in HFpEF
AU  - Anastasios Marathonitis
AU  - Artemis Anastasiou
AU  - Nikolaos Vythoulkas-Biotis
AU  - Niki Lama
AU  - Panagiotis Theofilis
AU  - Georgios Marinos
AU  - Angeliki Margoni
AU  - Aikaterini Tsatsaragkou
AU  - Kostas Zisimos
AU  - Antonios Lysandrou
AU  - Evangelos Oikonomou
AU  - Gerasimos Siasos
AU  - Dimitris Tousoulis
PY  - 2026
DA  - 2026/10/14
JO  - Scientific Reports
DO  - 10.1038/s41598-026-75671-1
UR  - https://www.nature.com/articles/s41598-026-75671-1
SN  - 2045-2322
ER  -